Aerosol is suspension of liquid or solid particles in a carrier gas,
which makes use of it for treatment of respiratory system related
diseases. Different forms of drugs can be utilized for aerosol
therapy such as solid particles, liquid particles, solutions, and
suspensions. Until recently, aerosol therapy concentrated primarily
on treatment of asthma and COPD for which, pressurized metered-dose
inhaler device was used. However, the role of aerosol therapy is
expanding beyond the initial focus. This expansion eliminated
CFC-based traditional metered-dose inhalers devices.
Report Overview @
https://www.transparencymarketresearch.com/aerosol-therapy-market.html
This will ultimately boost the market growth of aerosol therapy in
the field of gene therapy, inhalation therapy and vaccination.
Aerosol therapy is a natural and easiest way to treat asthma, COPD,
cystic fibrosis, and broncho pulmonary dysplasia (BPD). Aerosol
therapy is also used to deliver insulin, vaccines of influenza and
measles, and pain medications. Aerosol treatment therapy gives an
excellent and cost-efficient drug delivery. This therapy is effective
for patients who cannot use metered-dose inhalers; primary inhalation
devices are produced that guarantee breath-actuated aerosol delivery
with minimal side effects.
Aerosol therapy provides a fast and non-invasive way for treatment of
lung disorders as the drug is delivered at the receptor site.
Effectiveness of the therapy depends on how deeply aerosol particles
infiltrate into the bronchial track and where the particles are
deposited. A particle size under 2μm is ideal and can permeate up to
the peripheral airways. That is why most commercially available
aerosol devices produce droplets of roughly this size.
Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=15203
As per the World Health Organization, about half the cases of asthma
and COPD are due to hereditary weakness and the other cases are due
to environmental factors. The effect of pollution is likely to
intensify globally along with industrialization of areas, and
increasing the number of vehicles. Current government activities and
rising healthcare investments are drivers of aerosol therapy market,
which would upgrade over the examination time frame. Increasing
prices are major factor that is restraining the growth of the market
in terms of value.
Currently metered dose inhaler majorly contributes to the market and
is expected to dominate the market over the forecast period. As per
the data, COPD is third leading cause of death and fifth leading
cause of disability. Also, factors like increasing pollution,
improper lifestyles are the factors that drive the growth of the
market.
On the basis of regional presence, global aerosol therapy market is
segmented into five key regions viz. North America, Latin America,
Europe, Asia-Pacific, and the Middle East & Africa. Asthma
symptoms were detected in 26 million persons who live in the U.S., of
which, 19 million comprise adults and 7 million comprise children.
With this rate, North America is expected to dominate the market.
Asia Pacific (mostly China and India) market is estimated to grow at
a relatively fast rate over the forecast period.
Pre-Book Full Report @
https://www.transparencymarketresearch.com/checkout.php?rep_id=15203<ype=S
The largest manufacturers of aerosol therapy devices are Merck,
Boehringer Ingelheim GmbH, GlaxoSmithKline, and AstraZeneca Plc. In
2001, SmithKline Beecham and GlaxoWellcome merged together and became
GlaxoSmithKline, who became a key player in this field. Also,
Novartis AGTeva Pharmaceuticals, Opko Health, Omron Healthcare Co.,
Covidien plc., GE Healthcare Ltd., Philips Healthcare, Agilent
Technologies, Inc. Ltd, GF Health Products, Inc. are other important
players in this market.
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment